The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Fludrocortisone for the Prevention of Vasovagal Syncope
Open accessAbstract
Background There is limited evidence whether being on fludrocortisone prevents vasovagal syncope.Objectives The authors sought to determine whether treatment with fludrocortisone reduces the proportion of patients with recurrent vasovagal syncope by at least 40%, representing a pre-specified minimal clinically important relative risk reduction.Methods The multicenter POST 2 (Prevention of Syncope Trial 2) was a randomized, placebo-controlled, double-blind trial that assessed the effects of fludrocortisone in vasovagal syncope over a 1-year treatment period. All patients had >2 syncopal spells and a Calgary Syncope Symptom Score >-3. Patients received either fludrocortisone or matching placebo at highest tolerated doses from 0.05 mg to 0.2 mg daily. The main outcome measure was the first recurrence of syncope.Results The authors randomized 210 patients (71% female, median age 30 years) with a median 15 syncopal spells over a median of 9 years equally to fludrocortisone or placebo. Of these, 96 patients had ≥1 syncope recurrences, and only 14 patients were lost to follow-up before syncope recurrence. There was a marginally nonsignificant reduction in syncope in the fludrocortisone group (hazard ratio [HR]: 0.69: 95% confidence interval [CI]: 0.46 to 1.03; p = 0.069). In a multivariable model, fludrocortisone significantly reduced the likelihood of syncope (HR: 0.63; 95% CI: 0.42 to 0.94; p = 0.024). When the analysis was restricted to outcomes after 2 weeks of dose stabilization, there was a significant benefit due to fludrocortisone (HR: 0.51; 95% CI: 0.28 to 0.89; p = 0.019).Conclusions The study did not meet its primary objective of demonstrating that fludrocortisone reduced the likelihood of vasovagal syncope by the specified risk reduction of 40%. The study demonstrated a significant effect after dose stabilization, and there were significant findings in post hoc multivariable and on-treatment analyses. (A randomised clinical trial of fludrocortisone for the prevention of vasovagal syncope; ISRCTN51802652; Prevention of Syncope Trial 2 [POST 2]; NCT00118482).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the meantime, a similar number of patients discontinued fludrocortisone therapy owing to side effects, thus equating the benefit/risk ratio.”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [275]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although data from a 2016 RCT suggest fludrocortisone suppresses vasovagal syncope,52”
From Diagnosis and management of postural orthostatic tachycardia syndrome (2022) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“at 12 months, 44% of patients in the fludrocortisone arm continued to suffer syncope, a rate only slightly lower than the 60.5% rate observed in the placebo arm.”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [275]
The cited source says what the claim attributes to it.
In the citing paper
“The primary endpoint showed only a marginal non-significant reduction in syncope in the fludrocortisone group compared with the placebo group (hazard ratio 0.69, 95% CI 0.46-1.03; P =0.069)”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [275]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
Brignole, M., Menozzi, C., Moya, A., Andresen, D., Blanc, J. J., Krahn, A. D., Wieling, W., Beiras, X., Deharo, J. C., Russo, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.082313 · Cited by 437
Moher, D., Hopewell, S., Schulz, K. F., Montori, V. M., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D. R., Egger, M., & Altman, D. G. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.10.006 · Cited by 414
The elusive pathophysiology of neurally mediated syncope
Mosqueda-Garcia, R., Furlan, R., MD, J. T., & Fernandez-Violante, R. (2000) · Circulation · doi:10.1161/01.cir.102.23.2898 · Cited by 383
Effectiveness of Physical Counterpressure Maneuvers in Preventing Vasovagal Syncope
van Dijk, N., Quartieri, F., Blanc, J.-J., Garcia-Civera, R., Brignole, M., Moya, A., & Wieling, W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.059 · Cited by 315
Sheldon, R., Connolly, S., Rose, S., Klingenheben, T., Krahn, A., Morillo, C., Talajic, M., Ku, T., Fouad-Tarazi, F., Ritchie, D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.535161 · Cited by 278
El-Sayed, H., & HAINSWORTH, R. (1996) · Heart · doi:10.1136/hrt.75.2.134 · Cited by 261
Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt
Mosqueda-Garcia, R., Furlan, R., Fernandez-Violante, R., Desai, T., Snell, M., Jarai, Z., Ananthram, V, Robertson, R. M., & Robertson, D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119463 · Cited by 255
Diagnostic criteria for vasovagal syncope based on a quantitative history
Sheldon, R., Rose, S., Connolly, S., Ritchie, D., Koshman, M.-L., & Frenneaux, M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi584 · Cited by 252
Risk Factors for Syncope Recurrence After a Positive Tilt-Table Test in Patients With Syncope
Sheldon, R. S., Rose, S., Flanagan, P., Koshman, M. L., & Killam, S. (1996) · Circulation · doi:10.1161/01.cir.93.5.973 · Cited by 231
Rose, M. S., Koshman, M. L., Spreng, S., & Sheldon, R. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00257-2 · Cited by 216
Self-citationPlash, W. B., Diedrich, A., Biaggioni, I., Garland, E. M., Paranjape, S. Y., Black, B. K., Dupont, W. D., & Raj, S. R. (2013) · Clinical Science · doi:10.1042/cs20120276 · Cited by 128
Self-citationBrignole, M., Donateo, P., Tomaino, M., Massa, R., Iori, M., Beiras, X., Moya, A., Kus, T., Deharo, J. C., Giuli, S., et al. (2014) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001103 · Cited by 127
Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children
Salim, M. A., & Di Sessa, T. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.033 · Cited by 107
Verheyden, B., Liu, J., van Dijk, N., Westerhof, B. E., Reybrouck, T., Aubert, A. E., & Wieling, W. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.09.003 · Cited by 101
Claydon, V. E., & HAINSWORTH, R. (2004) · Hypertension · doi:10.1161/01.hyp.0000122269.05049.e7 · Cited by 97
Saklani, P., Krahn, A. D., & Klein, G. J. (2013) · Circulation · doi:10.1161/circulationaha.112.138396 · Cited by 91
Fu, Q., Verheyden, B., Wieling, W., & Levine, B. D. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224998 · Cited by 90
Neurocardiogenic syncope in children with a normal heart
Balaji, S., Oslizlok, P. C., Allen, M. C., McKay, C. A., & Gillette, P. C. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90768-4 · Cited by 78
Raj, S. R., Rose, S., Ritchie, D., & Sheldon, R. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.03.013 · Cited by 78
Epstein, A. E., Bigger, J. T., Wyse, D. G., Romhilt, D. W., Reynolds-Haertle, R. A., & Hallstrom, A. P. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80210-4 · Cited by 75
Age-Dependent Effect of β-Blockers in Preventing Vasovagal Syncope
Sheldon, R. S., Morillo, C. A., Klingenheben, T., Krahn, A. D., Sheldon, A., & Rose, M. S. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.112.974386 · Cited by 72
Gisolf, J., Westerhof, B. E., van Dijk, N., Wesseling, K. H., Wieling, W., & Karemaker, J. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.038 · Cited by 59
Malik, P. G., Koshman, M. L., & Sheldon, R. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00047-8 · Cited by 57
Pharmacotherapy of autonomic failure
Shibao, C. A., Okamoto, L. E., & Biaggioni, I. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.009 · Cited by 56
Abnormal reflex venous function in patients with neuromediated syncope
Manyari, D. E., Rose, S., Tyberg, J. V., & Sheldon, R. S. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00051-4 · Cited by 46
Tilt testing for syncope: a reappraisal.
Sheldon, R. S. (2005) · PubMed · Cited by 46
Mangru, N. N., Young, M., Mas, M. S., Chandar, J. S., Pearse, L. A., & Wolff, G. S. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90178-7 · Cited by 35
Liao, Y., Li, X., Zhang, Y., Chen, S., Tang, C., & Du, J. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01289.x · Cited by 21
Importance of competing risks in the analysis of anti-epileptic drug failure
Williamson, P. R., Smith, C. T., Sander, J. W. A. S., & Marson, A. G. (2007) · Trials · doi:10.1186/1745-6215-8-12 · Cited by 13
Flagged first, then by citations
Cited by
Sorted by citations
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.004 · Cited by 478
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya‐Mitjans, À., de Lange, F. J., Deharo, J., Elliot, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martiın, A., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0161 · Cited by 475
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000499 · Cited by 463
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000498 · Cited by 411
Metadata
- Authors
- Sheldon, R., Raj, S. R., Rose, M. S., Morillo, C. A., Krahn, A. D., Medina, E., Talajic, M., Kus, T., Seifer, C. M., Lelonek, M., Klingenheben, T., Parkash, R., Ritchie, D., McRae, M., Sheldon, R. S., Rose, S. M., Ritchie, D. A., McCrae, M., Morillo, C., Malcolm, V. M., Krahn, A. D., Spindler, B., Medina, E., Talajic, M., Kus, T., Langlois, A., Lelonek, M., Raj, S., Seifer, C., Gardner, M., Romeo, M., Poirier, P., Simpson, C., Abdollah, H., Reynolds, J., Dorian, P., Birnie, D., Giuffre, M., Gilligan, D., Benditt, D., Sheldon, R. S., Raj, S. R., Rose, M. S., Krahn, A., Morillo, C., & Medina, E.
- Affiliations
- University of Calgary (CA)
- Goethe University Frankfurt (DE)
- Dalhousie University (CA)
- Université de Montréal (CA)
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 68
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2465056121
- Cited by
- 155
- References
- 32
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 15 · 2023: 11 · 2022: 18 · 2021: 23 · 2020: 13 · 2019: 14 · 2018: 12 · 2017: 15 · 2016: 9
- FWCI
- 18.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Calgary
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Keywords
- fludrocortisone, vasovagal syncope, syncope prevention, recurrent syncope, risk mitigation, orthostatic hypotension, postural orthostatic tachycardia syndrome
- MeSH terms
- Adult, Double-Blind Method, Female, Fludrocortisone, Humans, Male, Middle Aged, Recurrence, Syncope, Vasovagal, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
